Cargando…
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
According to the American Cancer Society, more than 200,000 women will be diagnosed with invasive breast cancer each year and approximately 40,000 will die from the disease. The human leukocyte antigen (HLA) class I samples peptides derived from proteasomal degradation of cellular proteins and prese...
Autores principales: | Weidanz, Jon A., Doll, Krysten L., Mohana-Sundaram, Soumya, Wichner, Timea, Lowe, Devin B., Gimlin, Susanne, Wawro Weidanz, Debra, Magnusson, Robert, Hawkins, Oriana E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401383/ https://www.ncbi.nlm.nih.gov/pubmed/25867039 http://dx.doi.org/10.3791/52159 |
Ejemplares similares
-
Quantification of Neuropeptide Y with Picomolar Sensitivity Enabled by Guided-Mode Resonance Biosensors
por: Abdallah, Mohammad G., et al.
Publicado: (2019) -
Direct analysis of HLA/HER-2 peptide epitopes
por: Patterson, Andrea, et al.
Publicado: (2013) -
Resonant Photonic Biosensors with Polarization-Based Multiparametric Discrimination in Each Channel
por: Magnusson, Robert, et al.
Publicado: (2011) -
MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers
por: Tran, Nhat, et al.
Publicado: (2018) -
Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer
por: Yaman, Serkan, et al.
Publicado: (2020)